Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
MBBS, FCPS (Medicine), Fellowship in Endocrinology
Gastroenterologist
MBBS, MRCP (UK), FCPS (Gastroenterology), M.D (USA), Gastroenterology SCE (UK) , European Board of Gastroenterology and Hepatology (EBGH)
Gastroenterologist
MBBS, MRCP (UK), FCPS (Gastroenterology), M.D (USA), Gastroenterology SCE (UK) , European Board of Gastroenterology and Hepatology (EBGH)
Diabetologist
M.B.B.S, MRCGP, CDE (Certified Diabetes Educator), MCCEE
General Physician
M.B.B.S., Certified Diabetologist , Certified Hypertension Specialist
General Physician
M.B.B.S., Certified Diabetologist , Certified Hypertension Specialist
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Rheumatologist
MBBS, FCPS Medicine , FCPS (Rheumatology), MRCP SCE Rheumatology ( UK), EULAR Certficate of Rheumatic Diseae (UK)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures